Bone Health and Spinal Cord Injury with Prof Cathy Craven

Send us Fan MailWelcome to the seventh episode of series two of SCI Care: What Really Matters.This week our host Prof Ruth Marshall interviews Prof Cathy Craven to discuss osteoporosis, bone health and spinal cord injury. Prof. Craven is a Clinician Scientist appointed as an Associate Professor in the Department of Medicine, Division of Physical Medicine and Rehabilitation at the University of Toronto and has been in providing outpatient services to patients with spinal Cord injury in the community for over 19 years and is well acquainted with the physical, social and emotional berries to health after spinal cord injury. Prof. Craven’s clinical and research expertise is in the prevention and treatment of secondary health conditions among individuals living with spinal cord injury and their related health service needs. Her recent work has focused on the associations between changes in body composition and multimorbidity among individuals with chronic spinal cord injury.Prof Marshall has an interest in osteoporosis after SCI and how this issue is investigated and treated and therefore had a number of questions ranging from what interested Prof Craven about bone health and what are her current research projects. Join them as they discuss this topic and the different areas Prof Craven works on and how COVID-19 affected her work. Thank you for listening.If you have any questions or suggestions for future episodes or would like information on becoming an ISCoS member, please email [email protected]. If you would like to register for the 60th Anniversary Annual Scientific Meeting this September, click hereThis show is brought to you by ISCoS - you can follow us on Twitter @iscosmeetings, hosted by Prof Ruth Marshall produced and directed by Heather Pownallof Heather's Media Hub@heathershub*The opinions of our host and guests are their own.--- Send in a voice message: https://anchor.fm/scicare/messageThe opinions of our host and guests are their own; ISCoS does not endorse any individual viewpoints, given products or companies. You can follow us on Twitter and LinkedInContact us directly with any questions or comments at [email protected]